Latest filing published 26 Feb 2024 for Chimera Investment CORP, €52k.
Insider track record
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +18.4%Entry US$48.15 · Close at T+365 US$57.00
- +42.6%Entry US$40.65 · Close at T+365 US$57.96
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Choudhary Yarlagadda: trading record in brief
This profile gathers the share dealings of Choudhary Yarlagadda in Chimera Investment Corp, where the filings describe the role as chief executive. The record holds 37 filings, for trades running from 24 August 2015 to 22 February 2024.
No open-market sale appears; the market trades are 10 purchases worth €458k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 27 share grants.
The median purchase comes to €14k. On 7 out of 10 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. For 8 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +11.8%. These figures describe past trades and do not predict future prices.
On 26 February 2024 came the latest disclosure, a share grant for €52k in Chimera Investment Corp. The clock since the last published purchase (19 March 2020) now reads 2,426 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Choudhary Yarlagadda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,016 shares@ US$4.3640.0% of flowCommon StockSEC:0001628280-24-006897:0
- 3,286 shares@ US$4.992.0% of flowCommon StockSEC:0001157523-24-000009:1
- 35,210 shares0Common StockSEC:0001157523-24-000009:0
- 193,626 shares0Common StockSEC:0001157523-23-000496:0
- 11,183 shares@ US$7.5460.0% of flowCommon StockSEC:0001157523-23-000238:0
- 24,202 shares0Common StockSEC:0001157523-23-000011:0
- 40,347 shares0Common StockSEC:0001157523-22-000162:0
- 38,816 shares0Common StockSEC:0001157523-22-000013:0
- 50,930 shares0Common StockSEC:0001157523-21-000216:0
- 56,336 shares0Common StockSEC:0001157523-21-000012:0
- 500,000 shares0Common StockSEC:0001157523-21-000012:1
- 300 shares@ US$6.900.3% of flowCommon StockSEC:0001157523-20-000376:0
- 40,600 shares@ US$7.5040.2% of flowCommon StockSEC:0001157523-20-000376:1
- 81,236 shares0Common StockSEC:0001157523-20-000227:0
- 28,574 shares0Common StockSEC:0001157523-20-000022:0
- 5,743 shares@ US$18.5218.7% of flowCommon StockSEC:0001157523-19-000399:2
- 56,819 shares0Common StockSEC:0001157523-19-000399:0
- 107,274 shares0Common StockSEC:0001157523-19-000399:1
- 32,239 shares0Common StockSEC:0001157523-19-000026:0
- 54,789 shares0Common StockSEC:0001140361-18-009406:0
- 2,367 shares@ US$18.715.8% of flowCommon StockSEC:0001140361-17-008404:1
- 19,830 shares0Common StockSEC:0001140361-17-008404:0
- 1,400 shares@ US$16.092.8% of flowCommon StockSEC:0001140361-16-079677:0Canonical exit: 8 Dec 2016 (T+90)
- 265 shares@ US$16.080.5% of flowCommon StockSEC:0001140361-16-079677:1Canonical exit: 8 Dec 2016 (T+90)
- 640 shares@ US$16.131.3% of flowCommon StockSEC:0001140361-16-079677:2Canonical exit: 8 Dec 2016 (T+90)
25 of 35 declarations